Page last updated: 2024-11-04

temozolomide and Paralysis, Legs

temozolomide has been researched along with Paralysis, Legs in 2 studies

Research Excerpts

ExcerptRelevanceReference
"We report myelitis with consequent paraplegia as a potential neurological immune-related side effect of ipilimumab."1.40Late-onset paraplegia after complete response to two cycles of ipilimumab for metastatic melanoma. ( Ahmad, MW; Alken, S; Colleran, GC; Fitzpatrick, D; Kavanagh, EC; Kelly, CM; Lyons, TG; Murray, B; O'Kane, GM, 2014)
"Intramedullary gangliogliomas are indolent tumors of the spine with rare cases of malignant transformation."1.34Malignant transformation of conus medullaris ganglioglioma: case report. ( Amini, A; Chin, SS; Schmidt, MH, 2007)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
O'Kane, GM1
Lyons, TG1
Colleran, GC1
Ahmad, MW1
Alken, S1
Kavanagh, EC1
Fitzpatrick, D1
Murray, B1
Kelly, CM1
Amini, A1
Chin, SS1
Schmidt, MH1

Other Studies

2 other studies available for temozolomide and Paralysis, Legs

ArticleYear
Late-onset paraplegia after complete response to two cycles of ipilimumab for metastatic melanoma.
    Oncology research and treatment, 2014, Volume: 37, Issue:12

    Topics: Antibodies, Monoclonal; Antineoplastic Agents, Alkylating; Colitis; Dacarbazine; Fluorodeoxyglucose

2014
Malignant transformation of conus medullaris ganglioglioma: case report.
    Journal of neuro-oncology, 2007, Volume: 82, Issue:3

    Topics: Adult; Antineoplastic Agents; Combined Modality Therapy; Dacarbazine; Ganglioglioma; Glioblastoma; H

2007